JPH0582365B2 - - Google Patents
Info
- Publication number
- JPH0582365B2 JPH0582365B2 JP60093815A JP9381585A JPH0582365B2 JP H0582365 B2 JPH0582365 B2 JP H0582365B2 JP 60093815 A JP60093815 A JP 60093815A JP 9381585 A JP9381585 A JP 9381585A JP H0582365 B2 JPH0582365 B2 JP H0582365B2
- Authority
- JP
- Japan
- Prior art keywords
- iris
- skin
- vitamin
- extract
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 16
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 12
- 239000011677 pyridoxine Substances 0.000 claims description 6
- 235000008160 pyridoxine Nutrition 0.000 claims description 6
- 229940011671 vitamin b6 Drugs 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 210000003491 skin Anatomy 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 15
- 239000008213 purified water Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000006210 lotion Substances 0.000 description 12
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 239000003205 fragrance Substances 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 229940058015 1,3-butylene glycol Drugs 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 6
- 229960002216 methylparaben Drugs 0.000 description 6
- 239000000843 powder Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 206010013786 Dry skin Diseases 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- -1 methanol or ethanol Chemical compound 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 235000011118 potassium hydroxide Nutrition 0.000 description 3
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 241001627144 Iris versicolor Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- RCYWWJBNPIWJMJ-UHFFFAOYSA-N [4-(hexadecanoyloxymethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCCCCCCCCCC RCYWWJBNPIWJMJ-UHFFFAOYSA-N 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 150000003227 pyridoxines Chemical class 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 150000003697 vitamin B6 derivatives Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
産業上の利用分野
本発明は皮膚外用剤に関し、さらに詳しくは肌
荒れを防止し、肌荒れを改善する外、皮膚のたる
みや艶の消失などを防いで老化を防止する効果に
優れた、安全性の高い皮膚外用剤に関する。
従来の技術
化粧料などの皮膚外用剤には種々の薬効剤が配
合されており、肌荒れ防止や肌荒れ改善効果のあ
る薬効剤の開発が待望されているが、かかる効果
を有する薬効剤は現在までまだ見出されていな
い。
従来、ピリドキシン(即ち、ビタミンB6)又
はその誘導体は、肌荒れ改善に用いられてきた
が、その効果はいまだ十分ではなかつた。
発明が解決しようとする問題点
かかる現状に鑑み、本発明者らは肌荒れ防止及
び肌荒れ改善効果を有する皮膚外用剤を開発すべ
く鋭意研究を進めた結果、アイリス又はその抽出
液をピリドキシン又はその誘導体と共に配合する
ことによつて、肌荒れ防止及び肌荒れ改善効果に
優れ、かつ皮膚のたるみや艶などの消失を防いで
老化を防止する効果に優れた皮膚外用剤が得られ
ることを見い出し、本発明を完成するに至つた。
問題点を解決するための手段
すなわち、本発明はピリドキシン又はその誘導
体とアイリス又はその抽出液とを配合して成る皮
膚外用剤を提供するものである。
本発明に係る皮膚外用剤に配合されるアイリス
はアヤメ科のニオイアイリス、ムラサキアイリ
ス、シボリアイリスなどのアイリスの根であり、
イリジン、脂肪酸、タンニンなどが含まれてい
る。これらのアイリスの根は、粉末化して皮膚外
用剤に配合しても良いし、適当な溶媒で抽出した
抽出液として配合しても良い。
アイリスの抽出液は、例えば水、メタノールや
エタノールのような低級アルコール又は含水低級
アルコールなどのような適当な溶媒中でアイリス
の根を加熱還流し、濾過して得ることができ、一
般にはこの抽出液を濃縮して使用する。このよう
な方法で得られたアイリス抽出液は、溶媒を留去
後さらに、1,3−ブチレングリコールのような
溶媒に溶解したり、または得られた液を適当に濃
縮した濃縮物として、本発明に使用することもで
きる。別の方法として、アイリスの根を前記した
適当な抽出溶媒で抽出して得られる抽出物、ある
いはアイリスの根を熱水で抽出して得られる抽出
物をシリカゲルクロマトグラフイーなどの吸着系
クロマトグラフイーを用いて分画して得られた抽
出物を用いることもできる。
本発明に使用されるピリドキシンの誘導体、即
ちビタミンB6誘導体としては、ビタミンB6塩酸
塩、ビタミンB6ジオクタノエート、ビタミンB6
トリパルミテート、ビタミンB6ジパルミテート、
ビタミンB6ジラウレート、リン酸ピリドキサー
ル、グリチルレチン酸ピリドキシンなどをあげる
ことができる。本発明においてピリドキシン及び
その誘導体は単独又は任意の混合物として用いる
ことができる。
本発明におけるピリドキシン又はその誘導体の
配合量には特に限定はないが、好ましくは皮膚外
用剤全量中に、0.005〜2重量%更に好ましくは、
0.01〜1重量%配合される。
一方本発明におけるアイリスの配合量にも特に
限定はないが、一般には根の乾燥物を使用する場
合には皮膚外用剤全量中、0.001〜5重量%、根
の抽出物を使用する場合には皮膚外用剤全量中
0.001〜10重量%(更に好ましくは、0.01〜5重
量%)使用するのが好ましい。使用量が少なすぎ
ると本発明における目的効果が十分に発揮されな
い場合がある。
本発明の皮膚外用剤は、前記の必須成分に加え
て、必要に応じて、本発明の効果を損なわない範
囲内で、化粧品、医薬品等に一般に用いられる各
種成分、例えば水性成分、粉末成分、抽分、界面
活性剤、保湿剤、増粘剤、防腐剤、酸化防止剤、
香料、色剤、薬剤等を配合することができる。薬
剤の中でも特にビタミンB6又はその誘導体を配
合した時、顕著な効果が発揮される。
また本発明の皮膚外用剤の剤型は任意であり、
例えば化粧水等の可溶化系、乳液、クリーム等の
乳化系あるいは軟膏、分散液、粉末製品などの剤
型をとることができる。
発明の実施例及び効果
以下に本発明の実施例を説明するが、本発明の
範囲をこれらの実施例に限定するものでないこと
はいうまでもない。
実施例1:化粧水
(処方)
成分 %
アイリス抽出物※ 0.05
グリセリン 4.0
1,3−ブチレングリコール 4.0
エタノール 7.0
ポリオキシエチレン
オレイルアルコール 0.5
メチルパラベン 0.05
クエン酸 0.01
クエン酸ソーダ 0.1
ビタミンB6塩酸塩 0.1
香料 0.05
精製水 84.14
※:アイリスの根を充分水洗し、約5mmに細切
したもの10Kgに40%エタノール80を加え、50℃
で2日間浸漬した。これを濾過し、濾液を40℃で
5時間攪拌し、析出した沈澱物を濾過して除い
た。この濾液を50mmHg40℃にて減圧蒸留し、12
Kgとする。この液に1,3−ブチレングリコール
8Kgを加え、1時間攪拌した後、3日間静置し、
濾過して得た。
(製法)
精製水にクエン酸、クエン酸ソーダ、グリセリ
ン、1,3−ブチレングリコール、アイリス抽出
物、ビタミンB6塩酸塩を溶解した。別にエタノ
ールにポリオキシエチレンオレイルアルコール、
香料、メチルパラベンを溶解し、これを前述の精
製水溶液に加えて可溶化し、濾過して化粧水を得
た。
実施例2:クリーム
(処方)
成分 %
セトステアリルアルコール 3.5
スクワラン 40.0
ミツロウ 3.0
還元ラノリン 5.0
エチルパラベン 5.0
ポリオキシエレン(20)ソルビタンモノパル
ミチン酸エステル 2.0
ステアリン酸モノグリセリド 2.0
アイリス抽出物※ 1.0
香料 0.03
1,3−ブチレングリコール 5.0
グリセリン 5.0
ビタミンB6ジオクタノエート 0.1
精製水 33.07
※:アイリスの根を充分水洗し、約5mmに細切
したもの10Kgに70%エタノール100を加え、
50℃で2日間浸漬した。これを濾過し、濾液
を50mmHg40℃にて減圧蒸留し、40Kgとした。
(製法)
成分,,,,,,,を加熱溶
解し75℃に保つたものを、75℃に加温した,
,,とに攪拌しながら加えた。ホモミキ
サー処理し乳化粒子を細かくした後攪拌しながら
急冷し、クリームを得た。
実施例3:乳液
(処方)
成分 %
アイリス抽出物※ 0.001
ステアリン酸 1.5
セチルアルコール 0.5
ミツロウ 2.0
ポリオキシエチレン(10)モノオレイン酸エ
ステル 1.0
グリセリンモノステアリン酸エステル 1.0
クインスシード抽出物(5%水溶液) 20.0
プロピレングリコール 5.0
エタノール 3.0
エチルパラベン 0.3
香料 0.03
ビタミンB6塩酸塩 0.5
精製水 残余
※:アイリスき根を充分水洗し、約5mmに細切
したもの5Kgに水10を加え、加熱還流し
(10時間)濾過し、得られた濾液を3日間静
置し、濾過し濾液に水を加え、全量10とし
た。
(製法)
エタノールに香料を加えて溶解した(アルコー
ル相)。
精製水にプロピレングリコール、アイリス抽出
物、ビタミンB6塩酸塩を加え加熱溶解し70℃に
保つた(水相)。クインスシード抽出物を除く他
の成分を混合し、加熱溶解して70℃に保つた(油
相)。次に、水相に油相を加え予備乳化を行い、
ホモミキサーで均一に乳化した。これを攪拌しな
がらアルコール相とクインスシード抽出物を加
え、その後攪拌しながら30℃に冷却して乳液を得
た。
実施例4:パツク
(処方)
成分 %
アイリス抽出物※ 0.1
ホリビニルアルコール 15.0
ポリエチレングリコール 3.0
プロピレングリコール 7.0
エタノール 10.0
メチルパラベン 0.05
香料 0.05
ビタミンB6ジオクタノエート 0.3
精製水 64.50
※:アイリスの根を充分水洗し、約5mmに細切
したもの10Kgにメタノール50を加え、50℃
で2日間浸漬した。これを濾過し、濾液をシ
リカゲルカラムに通した。さらに溶出液を70
%エタノールとし、20をシリカゲルカラム
に通し溶出液を得た。
(製法)
精製水にポリエチレングリコール、プロピレン
グリコール、アイリス抽出物、メチルパラベンを
加え攪拌溶解した。つぎにポリビニルアルコール
を加え加熱攪拌し、ビタミンB6ジオクタノエー
ト、香料を溶解したエタノールを加え攪拌溶解し
てパツクを得た。
実施例5:頭皮用化粧料(スカルプトリートメン
ト)
(処方)
成分 %
アイリス抽出物※ 0.5
1,3−ブチレングリコール 6.5
ポリエチレングリコール1500 5.0
エタノール 5.5
苛性カリ 0.05
精製水 46.95
2−ヘキシルデシルパルミテート 10.0
スクワラン 5.0
ブチルパラベン 0.2
ビタミンC 0.15
香料 0.05
精製水 18.9
カルボキシビニルポリマー 0.2
ビタミンB6塩酸塩 1.0
※:アイリスの根を充分水洗し、約5mmに細切
したもの10Kgに1、3−ブチレングリコール
50を加え、50℃で2日間浸漬した。これを
濾過し、濾液を室温で5時間攪拌し、析出し
た沈澱物を濾過して除去した。濾液は1,3
−ブチレングリコールを加え、全量50とし
た。
(製法)
成分,,,とを75℃で溶解したもの
を、75℃に保つた成分,,,,とに
攪拌しながら添加し、さらに室温で攪拌溶解した
成分,と成分を添加し、攪拌しながら冷却
してスカルプトリートメントを得た。
実施例6:軟膏
(処方)
成分 %
アイリス抽出物※ 5.0
ステアリルアルコール 18.0
モクロウ 20.0
ポリオキシエチレン(10)モノオレイン酸エ
ステル 0.25
グリセリンモノステアリン酸エステル 0.25
ワセリン 40.0
ビタミンB6ジオクタノエート 0.2
精製水 16.3
※:アイリスの根を熱水で抽出し、抽出物をシ
リカゲルのカラムに吸着後、メタノールで溶
出したフラクシヨンをメタノール留去後エタ
ノールに溶解した。
(製法)
精製水を70℃に保ち(水相)、他の成分を70℃
にて混合溶解した。(油相)。次いで水相に油相を
加え、ホモミキサーで均一に乳化後冷却して軟膏
を得た。
実施例7:水性エツセンス
(処方)
成分 %
(A) 水 全量100
1,3−ブチレングリコール 5.0
D.P.G 5.0
カルボキシビニルポリマー 0.2
ビタミンB6塩酸塩 0.2
アイリス抽出物※ 2.0
(B) エタノール 10
POE(60)硬化ヒマシ油 1.0
香料 0.1
メチルパラベン 0.2
(C) 水酸化カリウム 0.1
※:アイリスの根を充分水洗し、約5mmに細切
したものを5Kgをさらに粉砕し、得られた粉
砕物をまず100メツシユの篩にかけ、さらに
325メツシユの篩にかけて平均粒子が約40ミ
クロンの粉末約2Kgを得た。
(製法)
(A)の水相部、(B)のアルコール相部をそ
れぞれ、室温にて均一溶解した後、水相(A)に
アルコール相(B)を加え均一に混合、可溶化し
た後に成分(C)の水酸化カリウムを加え中和増
粘して水性エッセンスを得た。
実施例8:粉末製品
(処方)
成分 %
(A) タルク 85.3
二酸化チタン 2.0
カオリン 2.0
アイリス粉砕物 5.0
ビタミンB6トリパルミテート 0.5
メチルパラベン 0.1
(B) スクワラン 5.0
香料 0.1
(製法)
香料をスクワランに溶かし、(A)を混合した
ものに噴霧し、さらに混合し粉砕して粉末製品を
得た。
肌荒れ改善効果
実施例1で得た化粧水と、実施例1の処方でア
イリス抽出物を配合しない(精製水で置換)化粧
水及びビタミンB6を配合しない(精製水で置換)
化粧水とを用いて、人体パネルで肌荒れ改善効果
試験を行つた。
すなわち、女性健常人(顔面)の皮膚表面形態
をミリスン樹脂によるレプリカ法を用いて肌のレ
プリカを取り顕微鏡(17倍)にて観察した。
皮紋の状態及び角層の剥離状態から第1表に示
す基準にもとづいて肌荒れを評価1,2と判断さ
た者(肌荒れパネル)30名を用い、顔面左右半々
に、実施例1で得た化粧水とアイリス抽出物を配
合しない化粧水またはビタミンB6を配合しない
化粧水を1日1回2週間塗布した。
2週間後、再び上述のレプリカ法にて肌の状態
を観察し、第1表の判定基準に従つて評価した。
結果は第2表に示した通りであつた。
INDUSTRIAL APPLICATION FIELD The present invention relates to a skin preparation for external use, and more specifically, it is a safe and effective skin preparation that not only prevents and improves rough skin, but also prevents skin sagging and loss of luster, thereby preventing aging. Regarding expensive skin external preparations. Conventional technology Various medicinal agents are blended into external skin preparations such as cosmetics, and the development of medicinal agents that have the effect of preventing or improving skin roughness is long awaited, but to date there are no medicinal agents that have such effects. It has not been discovered yet. Conventionally, pyridoxine (ie, vitamin B 6 ) or its derivatives have been used to improve rough skin, but the effects have not yet been sufficient. Problems to be Solved by the Invention In view of the current situation, the present inventors conducted intensive research to develop a skin preparation for external use that has the effect of preventing and improving skin roughness. It has been discovered that by blending with the above ingredients, it is possible to obtain a skin preparation that is excellent in preventing and improving skin roughness, as well as in preventing aging by preventing skin sagging and loss of luster, and has developed the present invention. It was completed. Means for Solving the Problems That is, the present invention provides an external skin preparation comprising pyridoxine or a derivative thereof and iris or an extract thereof. The iris contained in the skin external preparation according to the present invention is the root of the iris of the Iridaceae family, such as odor iris, purple iris, and iris iris,
Contains irisine, fatty acids, and tannins. These iris roots may be powdered and blended into external skin preparations, or may be blended as an extract extracted with an appropriate solvent. An iris extract can be obtained by heating iris roots in a suitable solvent such as water, a lower alcohol such as methanol or ethanol, or a water-containing lower alcohol, followed by filtration. Concentrate the liquid before use. After the solvent is distilled off, the iris extract obtained by such a method is further dissolved in a solvent such as 1,3-butylene glycol, or the obtained liquid is appropriately concentrated to make a concentrate. It can also be used for inventions. Alternatively, the extract obtained by extracting the iris root with the above-mentioned suitable extraction solvent, or the extract obtained by extracting the iris root with hot water, can be subjected to adsorption chromatography such as silica gel chromatography. It is also possible to use an extract obtained by fractionation using E. The derivatives of pyridoxine, that is, vitamin B 6 derivatives used in the present invention include vitamin B 6 hydrochloride, vitamin B 6 dioctanoate, vitamin B 6
tripalmitate, vitamin B6 dipalmitate,
Examples include vitamin B6 dilaurate, pyridoxal phosphate, and pyridoxine glycyrrhetinate. In the present invention, pyridoxine and its derivatives can be used alone or in any mixture. The amount of pyridoxine or its derivative in the present invention is not particularly limited, but preferably 0.005 to 2% by weight in the total amount of the skin external preparation, more preferably,
It is blended in an amount of 0.01 to 1% by weight. On the other hand, there is no particular limitation on the amount of iris blended in the present invention, but in general, when the dried root is used, it is 0.001 to 5% by weight of the total amount of the skin external preparation, and when the root extract is used, it is 0.001 to 5% by weight of the total amount of the skin external preparation. Total volume of skin external preparations
It is preferable to use 0.001 to 10% by weight (more preferably 0.01 to 5% by weight). If the amount used is too small, the intended effects of the present invention may not be fully exhibited. In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention may optionally contain various ingredients commonly used in cosmetics, pharmaceuticals, etc., such as aqueous ingredients, powder ingredients, etc., as long as they do not impair the effects of the present invention. extract, surfactant, humectant, thickener, preservative, antioxidant,
Flavors, colorants, drugs, etc. can be added. Among drugs, especially when vitamin B 6 or its derivatives are combined, remarkable effects are exhibited. Further, the dosage form of the skin external preparation of the present invention is arbitrary,
For example, it can take the form of a solubilized system such as a lotion, an emulsified system such as a milky lotion or a cream, or a dosage form such as an ointment, a dispersion, or a powder product. Examples and Effects of the Invention Examples of the present invention will be described below, but it goes without saying that the scope of the present invention is not limited to these examples. Example 1: Lotion (prescription) Ingredients % Iris extract* 0.05 Glycerin 4.0 1,3-butylene glycol 4.0 Ethanol 7.0 Polyoxyethylene oleyl alcohol 0.5 Methylparaben 0.05 Citric acid 0.01 Sodium citrate 0.1 Vitamin B 6 hydrochloride 0.1 Fragrance 0.05 Purified water 84.14 *: Wash iris roots thoroughly and cut them into approximately 5 mm pieces, add 40% ethanol 80 to 10 kg, and boil at 50℃.
Soaked for 2 days. This was filtered, the filtrate was stirred at 40°C for 5 hours, and the precipitate that had separated out was removed by filtration. This filtrate was distilled under reduced pressure at 50 mmHg and 40°C.
Kg. 8 kg of 1,3-butylene glycol was added to this solution, stirred for 1 hour, and left to stand for 3 days.
Obtained by filtration. (Production method) Citric acid, sodium citrate, glycerin, 1,3-butylene glycol, iris extract, and vitamin B 6 hydrochloride were dissolved in purified water. Separately, ethanol and polyoxyethylene oleyl alcohol,
Fragrance and methylparaben were dissolved, added to the above-mentioned purified aqueous solution to solubilize, and filtered to obtain a lotion. Example 2: Cream (prescription) ingredients % Cetostearyl alcohol 3.5 Squalane 40.0 Beeswax 3.0 Reduced lanolin 5.0 Ethylparaben 5.0 Polyoxyethylene (20) Sorbitan monopalmitate 2.0 Stearic acid monoglyceride 2.0 Iris extract* 1.0 Fragrance 0.03 1,3 -Butylene glycol 5.0 Glycerin 5.0 Vitamin B 6- dioctanoate 0.1 Purified water 33.07 *: Wash the iris root thoroughly with water, cut it into approximately 5 mm pieces, add 70% ethanol 100 to 10 kg,
It was soaked at 50°C for 2 days. This was filtered, and the filtrate was distilled under reduced pressure at 50 mmHg and 40°C to weigh 40 kg. (Manufacturing method) The ingredients were melted by heating and kept at 75℃, then heated to 75℃,
,, with stirring. After treatment with a homomixer to make emulsified particles fine, the mixture was rapidly cooled while stirring to obtain cream. Example 3: Emulsion (formulation) ingredients % Iris extract * 0.001 Stearic acid 1.5 Cetyl alcohol 0.5 Beeswax 2.0 Polyoxyethylene (10) monooleate 1.0 Glycerin monostearate 1.0 Quince seed extract (5% aqueous solution) 20.0 Propylene glycol 5.0 Ethanol 3.0 Ethylparaben 0.3 Fragrance 0.03 Vitamin B 6 hydrochloride 0.5 Purified water Remaining *: Wash the iris roots thoroughly and cut them into approximately 5 mm pieces. Add 10 kg of water to 5 kg and heat under reflux (10 hours). The resulting filtrate was left to stand for 3 days, and water was added to the filtrate to make a total volume of 10. (Manufacturing method) A fragrance was added and dissolved in ethanol (alcohol phase). Propylene glycol, iris extract, and vitamin B 6 hydrochloride were added to purified water, dissolved by heating, and kept at 70°C (aqueous phase). Other ingredients except quince seed extract were mixed, heated and dissolved and kept at 70°C (oil phase). Next, the oil phase is added to the water phase for preliminary emulsification.
It was uniformly emulsified using a homomixer. The alcohol phase and quince seed extract were added to this while stirring, and then cooled to 30°C while stirring to obtain a milky lotion. Example 4: Pack (prescription) Ingredients % Iris extract * 0.1 Holivinyl alcohol 15.0 Polyethylene glycol 3.0 Propylene glycol 7.0 Ethanol 10.0 Methylparaben 0.05 Fragrance 0.05 Vitamin B 6- dioctanoate 0.3 Purified water 64.50 *: Wash the iris root thoroughly with water and prepare approximately Add 50% methanol to 10kg of 5mm pieces and heat at 50°C.
Soaked for 2 days. This was filtered and the filtrate was passed through a silica gel column. Further eluate 70
% ethanol and passed through a silica gel column to obtain an eluate. (Manufacturing method) Polyethylene glycol, propylene glycol, iris extract, and methylparaben were added to purified water and dissolved with stirring. Next, polyvinyl alcohol was added and stirred with heating, and ethanol in which vitamin B 6 dioctanoate and fragrance were dissolved was added and dissolved with stirring to obtain a pack. Example 5: Scalp cosmetics (scalp treatment) (Formulation) Ingredients % Iris extract* 0.5 1,3-butylene glycol 6.5 Polyethylene glycol 1500 5.0 Ethanol 5.5 Caustic potash 0.05 Purified water 46.95 2-hexyldecyl palmitate 10.0 Squalane 5.0 Butyl Parabens 0.2 Vitamin C 0.15 Fragrance 0.05 Purified water 18.9 Carboxyvinyl polymer 0.2 Vitamin B 6 hydrochloride 1.0 *: Iris root thoroughly washed with water and cut into approximately 5 mm pieces, 10 kg of 1,3-butylene glycol
50 was added and immersed at 50°C for 2 days. This was filtered, the filtrate was stirred at room temperature for 5 hours, and the precipitate deposited was removed by filtration. The filtrate is 1,3
- Butylene glycol was added to make the total amount 50. (Manufacturing method) Components, , , and are dissolved at 75℃ and added to the components , , , and kept at 75℃ with stirring, and then the components , , and dissolved at room temperature are added and stirred. While cooling, a scalp treatment was obtained. Example 6: Ointment (prescription) Ingredients % Iris extract * 5.0 Stearyl alcohol 18.0 Japanese wax 20.0 Polyoxyethylene (10) monooleate 0.25 Glycerin monostearate 0.25 Vaseline 40.0 Vitamin B 6- dioctanoate 0.2 Purified water 16.3 *: Iris The roots were extracted with hot water, the extract was adsorbed on a silica gel column, and the fraction eluted with methanol was dissolved in ethanol after the methanol was distilled off. (Manufacturing method) Purified water is kept at 70℃ (water phase), and other ingredients are kept at 70℃.
The mixture was mixed and dissolved. (oil phase). Next, the oil phase was added to the water phase, uniformly emulsified using a homomixer, and then cooled to obtain an ointment. Example 7: Aqueous essence (prescription) component % (A) Water Total amount 100 1,3-butylene glycol 5.0 DPG 5.0 Carboxy vinyl polymer 0.2 Vitamin B 6 hydrochloride 0.2 Iris extract* 2.0 (B) Ethanol 10 POE (60) Hydrogenated castor oil 1.0 Fragrance 0.1 Methylparaben 0.2 (C) Potassium hydroxide 0.1 *: Wash the iris root thoroughly with water, cut it into pieces of about 5 mm, and then crush 5 kg of it. First, pass the resulting crushed product through a 100-mesh sieve. Sprinkle on top and then
Approximately 2 kg of powder with an average particle size of approximately 40 microns was obtained by passing through a 325 mesh sieve. (Production method) After uniformly dissolving the aqueous phase part of (A) and the alcohol phase part of (B) at room temperature, the alcohol phase (B) is added to the aqueous phase (A), mixed uniformly, and then solubilized. Component (C) potassium hydroxide was added to neutralize and increase the viscosity to obtain an aqueous essence. Example 8: Powder product (formulation) ingredient % (A) Talc 85.3 Titanium dioxide 2.0 Kaolin 2.0 Iris crushed 5.0 Vitamin B 6 tripalmitate 0.5 Methylparaben 0.1 (B) Squalane 5.0 Fragrance 0.1 (Production method) Dissolve the fragrance in squalane, (A) was sprayed onto the mixture, further mixed and pulverized to obtain a powder product. Effect on improving rough skin: The lotion obtained in Example 1 and the formulation of Example 1 without iris extract (replaced with purified water) and without the combination of lotion and vitamin B 6 (replaced with purified water)
Using the lotion, we conducted a test on skin improvement effects using human body panels. That is, the skin surface morphology of a healthy female subject (facial) was observed under a microscope (17x magnification) by taking a skin replica using the replica method using Millisne resin. Thirty people (skin roughness panel) who judged their rough skin to be rated 1 or 2 based on the condition of skin marks and peeling of the stratum corneum based on the criteria shown in Table 1, were given the results obtained in Example 1 on the left and right half of their faces. A lotion without iris extract or a lotion without vitamin B6 was applied once a day for two weeks. Two weeks later, the skin condition was observed again using the replica method described above and evaluated according to the criteria in Table 1. The results were as shown in Table 2.
【表】【table】
【表】
第2表の結果から、アイリス抽出物及びビタミ
ンB6配合の化粧水を使用した顔面部位は他の化
粧水を使用した顔面部位と比較し、顕著な肌荒れ
改善効果が認められることが明らかである。[Table] From the results in Table 2, it can be seen that the facial area using the lotion containing iris extract and vitamin B 6 has a remarkable effect on improving rough skin compared to the facial area using other lotions. it is obvious.
Claims (1)
はその抽出液を配合して成ることを特徴とする皮
膚外用剤。1. A skin preparation for external use, characterized by containing pyridoxine or a derivative thereof and iris or an extract thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60093815A JPS61254510A (en) | 1985-05-02 | 1985-05-02 | External agent for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60093815A JPS61254510A (en) | 1985-05-02 | 1985-05-02 | External agent for skin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61254510A JPS61254510A (en) | 1986-11-12 |
| JPH0582365B2 true JPH0582365B2 (en) | 1993-11-18 |
Family
ID=14092894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60093815A Granted JPS61254510A (en) | 1985-05-02 | 1985-05-02 | External agent for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61254510A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1000966B (en) * | 1992-02-28 | 1993-03-16 | Platon Dimitriou | Process for the production of a preparation for the protection of the human skin. |
| FR2746641B1 (en) * | 1996-03-27 | 1998-06-05 | Oreal | USE OF AN EXTRACT OF AT LEAST ONE IRIDACEA IN THE TREATMENT OF WRINKLES |
| JP3142245B2 (en) * | 1996-06-28 | 2001-03-07 | 株式会社資生堂 | External preparation for skin |
| ES2116243B1 (en) * | 1996-12-24 | 1999-03-01 | Vicente Rojas Isabel | TOPICAL USE POMADA APPLICABLE AGAINST BURNS AND SKIN CONDITIONS IN GENERAL. |
| US7235249B2 (en) * | 2002-03-28 | 2007-06-26 | The Procter & Gamble Company | Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions |
-
1985
- 1985-05-02 JP JP60093815A patent/JPS61254510A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61254510A (en) | 1986-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3499616B2 (en) | Application to hydroxytyrosol, melanin production inhibitor or lipid peroxide production inhibitor | |
| JPH06199646A (en) | Skin beautifying cosmetic | |
| JPS61291515A (en) | Cosmetic | |
| JP2009029734A (en) | External preparation for skin | |
| JPH08301779A (en) | External preparation for atopic dermatitis | |
| JPH08133952A (en) | Skin preparation for external use | |
| JPH0582365B2 (en) | ||
| JPH03127714A (en) | Skin cosmetic | |
| JPH11171723A (en) | Antioxidant | |
| JPH0532556A (en) | Skin agent for external use | |
| JPH1036282A (en) | Agent for suppressing breakage of mucopolysaccharide | |
| JP2501593B2 (en) | Topical agent for suppressing melanin production | |
| JPH11246337A (en) | Anti-aging agent | |
| JP2003137742A (en) | Hair growing agent comprising evolvulus plant extract and other galenical extract | |
| JP2001048740A (en) | Blood circulation accelerator | |
| JP3091040B2 (en) | Skin cosmetics | |
| JP2003012495A (en) | Cosmetics | |
| WO2002051374A1 (en) | Hair growth inhibitors and compositions containing the same | |
| JP3359774B2 (en) | External preparation for skin | |
| JPH0643293B2 (en) | External skin preparation | |
| JP2001261545A (en) | Skin care preparation for prevention of chapped skin | |
| JP4105498B2 (en) | A composition effective for prevention and alleviation of symptoms of atopic disease | |
| JPH08133948A (en) | Skin preparation for external use | |
| JP2855274B2 (en) | Hair restoration | |
| JPH04321616A (en) | Skin medicine for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |